Aurinia Pharmaceuticals (AUPH) Competitors $8.42 +0.18 (+2.18%) (As of 10:08 AM ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends AUPH vs. RCKT, IGMS, YMAB, CYRX, KROS, BHVN, AXSM, ALKS, BBIO, and RAREShould you be buying Aurinia Pharmaceuticals stock or one of its competitors? The main competitors of Aurinia Pharmaceuticals include Rocket Pharmaceuticals (RCKT), IGM Biosciences (IGMS), Y-mAbs Therapeutics (YMAB), Cryoport (CYRX), Keros Therapeutics (KROS), Biohaven (BHVN), Axsome Therapeutics (AXSM), Alkermes (ALKS), BridgeBio Pharma (BBIO), and Ultragenyx Pharmaceutical (RARE). These companies are all part of the "pharmaceutical preparations" industry. Aurinia Pharmaceuticals vs. Rocket Pharmaceuticals IGM Biosciences Y-mAbs Therapeutics Cryoport Keros Therapeutics Biohaven Axsome Therapeutics Alkermes BridgeBio Pharma Ultragenyx Pharmaceutical Aurinia Pharmaceuticals (NASDAQ:AUPH) and Rocket Pharmaceuticals (NASDAQ:RCKT) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their community ranking, institutional ownership, media sentiment, dividends, analyst recommendations, earnings, risk, profitability and valuation. Is AUPH or RCKT more profitable? Rocket Pharmaceuticals has a net margin of 0.00% compared to Aurinia Pharmaceuticals' net margin of -10.23%. Aurinia Pharmaceuticals' return on equity of -4.41% beat Rocket Pharmaceuticals' return on equity.Company Net Margins Return on Equity Return on Assets Aurinia Pharmaceuticals-10.23% -4.41% -3.07% Rocket Pharmaceuticals N/A -62.62%-54.17% Does the MarketBeat Community favor AUPH or RCKT? Aurinia Pharmaceuticals received 182 more outperform votes than Rocket Pharmaceuticals when rated by MarketBeat users. Likewise, 73.21% of users gave Aurinia Pharmaceuticals an outperform vote while only 73.12% of users gave Rocket Pharmaceuticals an outperform vote. CompanyUnderperformOutperformAurinia PharmaceuticalsOutperform Votes57173.21% Underperform Votes20926.79% Rocket PharmaceuticalsOutperform Votes38973.12% Underperform Votes14326.88% Which has better valuation & earnings, AUPH or RCKT? Aurinia Pharmaceuticals has higher revenue and earnings than Rocket Pharmaceuticals. Aurinia Pharmaceuticals is trading at a lower price-to-earnings ratio than Rocket Pharmaceuticals, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAurinia Pharmaceuticals$175.51M6.87-$78.02M-$0.15-56.13Rocket PharmaceuticalsN/AN/A-$245.60M-$2.75-4.72 Do analysts rate AUPH or RCKT? Aurinia Pharmaceuticals currently has a consensus price target of $10.00, suggesting a potential upside of 18.76%. Rocket Pharmaceuticals has a consensus price target of $51.00, suggesting a potential upside of 292.91%. Given Rocket Pharmaceuticals' stronger consensus rating and higher possible upside, analysts plainly believe Rocket Pharmaceuticals is more favorable than Aurinia Pharmaceuticals.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Aurinia Pharmaceuticals 0 Sell rating(s) 1 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.75Rocket Pharmaceuticals 0 Sell rating(s) 1 Hold rating(s) 10 Buy rating(s) 0 Strong Buy rating(s) 2.91 Does the media prefer AUPH or RCKT? In the previous week, Rocket Pharmaceuticals had 18 more articles in the media than Aurinia Pharmaceuticals. MarketBeat recorded 25 mentions for Rocket Pharmaceuticals and 7 mentions for Aurinia Pharmaceuticals. Aurinia Pharmaceuticals' average media sentiment score of 0.86 beat Rocket Pharmaceuticals' score of 0.32 indicating that Aurinia Pharmaceuticals is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Aurinia Pharmaceuticals 3 Very Positive mention(s) 2 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Rocket Pharmaceuticals 5 Very Positive mention(s) 1 Positive mention(s) 8 Neutral mention(s) 3 Negative mention(s) 0 Very Negative mention(s) Neutral Which has more volatility & risk, AUPH or RCKT? Aurinia Pharmaceuticals has a beta of 1.45, meaning that its stock price is 45% more volatile than the S&P 500. Comparatively, Rocket Pharmaceuticals has a beta of 1.09, meaning that its stock price is 9% more volatile than the S&P 500. Do insiders and institutionals believe in AUPH or RCKT? 36.8% of Aurinia Pharmaceuticals shares are held by institutional investors. Comparatively, 98.4% of Rocket Pharmaceuticals shares are held by institutional investors. 4.3% of Aurinia Pharmaceuticals shares are held by company insiders. Comparatively, 28.5% of Rocket Pharmaceuticals shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term. SummaryAurinia Pharmaceuticals beats Rocket Pharmaceuticals on 9 of the 17 factors compared between the two stocks. Ad DTIDownload Our Tesla Ebook For FreeLike many of you, we here at the TradingPub are bullish on Tesla long term. We believe the company will continue to be a leader in technology, EVs and A.I. We also believe it’s share price will be rewarded in a big way… In fact, our #1 Tesla expert just published a brand new Ebook regarding Tesla’s future, and we’d like to send it to you at no cost.To claim your copy free of charge simply follow this link. Get Aurinia Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for AUPH and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart AUPH vs. The Competition Export to ExcelMetricAurinia PharmaceuticalsPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$1.21B$6.48B$5.07B$8.80BDividend YieldN/A8.11%4.99%4.07%P/E Ratio-56.134.9789.5613.60Price / Sales6.87371.451,224.8087.40Price / CashN/A52.5939.4536.27Price / Book3.1110.306.976.33Net Income-$78.02M$153.61M$119.04M$225.93M7 Day Performance1.08%-1.73%-1.78%-0.96%1 Month Performance17.43%-7.26%-3.59%1.06%1 Year Performance-3.66%31.10%31.64%26.59% Aurinia Pharmaceuticals Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)AUPHAurinia Pharmaceuticals1.6876 of 5 stars$8.42+2.2%$10.00+18.8%-10.8%$1.21B$175.51M-56.13300RCKTRocket Pharmaceuticals4.4162 of 5 stars$12.98-0.5%$51.00+292.9%-40.8%$1.18BN/A-4.74240Analyst ForecastAnalyst RevisionIGMSIGM Biosciences4.7018 of 5 stars$9.60-1.7%$16.13+68.0%+63.3%$570.82M$2.13M0.00190YMABY-mAbs Therapeutics3.3273 of 5 stars$10.39-1.4%$21.38+105.7%+100.8%$465.37M$84.82M0.00150Analyst ForecastCYRXCryoport2.8991 of 5 stars$6.38-2.9%$12.50+95.9%-52.6%$315.36M$233.26M-1.941,170Insider TradeKROSKeros Therapeutics3.4913 of 5 stars$53.28-1.6%$88.89+66.8%+80.5%$2.16B$150,000.000.00100BHVNBiohaven3.9207 of 5 stars$45.54-2.8%$63.42+39.3%+53.0%$4.61B$462.51M0.00239AXSMAxsome Therapeutics4.6663 of 5 stars$95.00+0.4%$124.93+31.5%+57.6%$4.60B$270.60M-14.49589Analyst UpgradeALKSAlkermes4.7847 of 5 stars$27.85-0.2%$35.42+27.2%+15.4%$4.51B$1.66B14.312,100Positive NewsBBIOBridgeBio Pharma4.5795 of 5 stars$23.21+0.7%$47.57+105.0%-21.2%$4.39B$9.30M0.00400Insider TradeAnalyst RevisionRAREUltragenyx Pharmaceutical4.6401 of 5 stars$46.46+0.1%$86.69+86.6%+17.9%$4.29B$434.25M-7.181,276 Related Companies and Tools Related Companies RCKT Alternatives IGMS Alternatives YMAB Alternatives CYRX Alternatives KROS Alternatives BHVN Alternatives AXSM Alternatives ALKS Alternatives BBIO Alternatives RARE Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:AUPH) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Aurinia Pharmaceuticals Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Aurinia Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free AUPH Stock Alerts